HDAC9 and breast carcinoma: In other tumors, high expression of HDAC9 was usually associated with poor prognosis in patients, such as pancreatic cancer (Li et al., 2020), breast cancer (Huang et al., 2018), and oral squamous cancer (Rastogi et al., 2016).